Average Insider

Where insiders trade, we follow

$HLN
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Brian James McNamara
CEO
24561
Employees
$10.10
Current Price
$50.07B
Market Cap
52W Low$8.65
Current$10.1055.1% above low, 44.9% below high
52W High$11.28

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00---
Sells00--
3 monthsBuys00---
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
No insider transactions found

Upcoming Earnings

Scheduled earnings reports
Jul 30, 2026
EPS
Estimated$0.27
ActualN/A
Revenue
Estimated$7.43B
ActualN/A

Past Earnings

Historical earnings results
Apr 29, 2026
EPS
Estimated$0.25
ActualN/A
Revenue
Estimated$7.57B
ActualN/A
4 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.7.3